Abstract
Cholinesterase inhibitors play an essential role in the treatment of Alzheimer’s disease. Since their first introduction over a decade ago, they are an indispensable part of Alzheimer’s disease therapy and remain at the forefront of scientific interest worldwide. In this manuscript new analogs of THA and 7-MEOTA were designed, synthesized, and evaluated for their inhibitory activity against both acetylcholinesterase and butyrylcholinesterase. Cholinergic properties were investigated and quantified with respect to their side chain residues (aromatic or alicyclic). All synthesized compounds proved to have potent inhibitory activity at micromolar range. Moreover, compound 4 demonstrated promising efficacy and appears to be an ideal candidate for further testing.
Keywords: 7-methoxytacrine, acetylcholinesterase, Alzheimer`s disease, butyrylcholinesterase, inhibition selectivity, molecular modelling.
Letters in Organic Chemistry
Title:Comparison of Novel Tacrine and 7-MEOTA Derivatives with Aromatic and Alicyclic Residues: Synthesis, Biological Evaluation and Docking Studies
Volume: 10 Issue: 4
Author(s): Jan Korabecny, Ladislav Janovec, Kamil Musilek, Filip Zemek, Anna Horova, Eugenie Nepovimova, Rafael Dolezal, Veronika Opletalova, Jana Hroudova, Zdenek Fisar, Young-Sik Jung and Kamil Kuca
Affiliation:
Keywords: 7-methoxytacrine, acetylcholinesterase, Alzheimer`s disease, butyrylcholinesterase, inhibition selectivity, molecular modelling.
Abstract: Cholinesterase inhibitors play an essential role in the treatment of Alzheimer’s disease. Since their first introduction over a decade ago, they are an indispensable part of Alzheimer’s disease therapy and remain at the forefront of scientific interest worldwide. In this manuscript new analogs of THA and 7-MEOTA were designed, synthesized, and evaluated for their inhibitory activity against both acetylcholinesterase and butyrylcholinesterase. Cholinergic properties were investigated and quantified with respect to their side chain residues (aromatic or alicyclic). All synthesized compounds proved to have potent inhibitory activity at micromolar range. Moreover, compound 4 demonstrated promising efficacy and appears to be an ideal candidate for further testing.
Export Options
About this article
Cite this article as:
Korabecny Jan, Janovec Ladislav, Musilek Kamil, Zemek Filip, Horova Anna, Nepovimova Eugenie, Dolezal Rafael, Opletalova Veronika, Hroudova Jana, Fisar Zdenek, Jung Young-Sik and Kuca Kamil, Comparison of Novel Tacrine and 7-MEOTA Derivatives with Aromatic and Alicyclic Residues: Synthesis, Biological Evaluation and Docking Studies, Letters in Organic Chemistry 2013; 10 (4) . https://dx.doi.org/10.2174/1570178611310040011
DOI https://dx.doi.org/10.2174/1570178611310040011 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Science of Hypoglycemia in Patients with Diabetes
Current Diabetes Reviews Penicillium marneffei and its Pulmonary Involvements
Current Respiratory Medicine Reviews Molecular Interactions of Different Steroids Contributing to Sebum Production. Review
Current Drug Targets Pharmaceutical Approaches for Optimizing Oral Anti-Inflammatory Delivery Systems
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry NF-κ B and Rheumatic Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets A New Glucocorticoid Hypothesis of Brain Aging: Implications for Alzheimers Disease
Current Alzheimer Research Hypertension in Pregnancy: Pathophysiology & Management Strategies
Current Pharmaceutical Design Using Endogenous Neural Stem Cells to Enhance Recovery from Ischemic Brain Injury
Current Neurovascular Research Meet Our Editorial Board Member:
Current Neuropharmacology Local Cerebral Blood Flow is Preserved in Sepsis
Current Neurovascular Research Radionuclide Imaging in Patients with Ischemic Heart Failure
Current Medical Imaging P2X Receptors, Sensory Neurons and Pain
Current Medicinal Chemistry Editorial: Pain in Dementia: A Distressing Combination of Several Factors
Current Alzheimer Research Sleep-Wake Patterns and Cognition of Older Adults with Amnestic Mild Cognitive Impairment (aMCI): A Comparison with Cognitively Healthy Adults and Moderate Alzheimer’s Disease Patients
Current Alzheimer Research Bacteriophage - A Common Divergent Therapeutic Approach for Alzheimer's Disease and Type II Diabetes Mellitus
CNS & Neurological Disorders - Drug Targets Difficulties in Describing Allergic Disease Modulation by Pre-, Pro- and Synbiotics
Current Pharmaceutical Design Cellular Internalization of Quantum Dots Mediated by Cell-Penetrating Peptides
Pharmaceutical Nanotechnology Personalized Medicine in Psoriasis: Concept and Applications
Current Vascular Pharmacology Respiratory Viruses, Eosinophil Activation, and Early Allergen Sensitization - Early Life Predictors of Persistent Wheezing and Asthma
Current Pediatric Reviews Anti-Inflammatory, Analgesic and Anti-Nociceptive Efficacy of Peel of <i>Abelmoschus esculentus</i> Fruits in Laboratory Animal
Current Drug Therapy